11.61
price up icon37.07%   3.14
after-market Handel nachbörslich: 11.64 0.03 +0.26%
loading

Astria Therapeutics Inc Aktie (ATXS) Neueste Nachrichten

pulisher
09:05 AM

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Astria Therapeutics, Inc. (NASDAQ: ATXS) - WV News

09:05 AM
pulisher
06:59 AM

Astria Therapeutics (ATXS) Acquisition Sparks Interest in Naveni - GuruFocus

06:59 AM
pulisher
05:22 AM

Oppenheimer downgrades Astria Therapeutics stock rating to Perform on BioCryst acquisition - Investing.com UK

05:22 AM
pulisher
04:44 AM

Low frequency sounds good to Biocryst in $700M Astria HAE buy - BioWorld MedTech

04:44 AM
pulisher
04:33 AM

Astria Therapeutics (ATXS) Acquisition Boosts Confidence in BioC - GuruFocus

04:33 AM
pulisher
02:37 AM

ATXS Rating Downgraded: Jefferies Lowers Price Target | ATXS Sto - GuruFocus

02:37 AM
pulisher
01:48 AM

BioCryst to Acquire Astria in $700M Deal - USA Herald

01:48 AM
pulisher
01:17 AM

Covington, Sidley Guide $700M BioCryst Allergic Disease Deal - Law360

01:17 AM
pulisher
01:09 AM

Dow Jumps Over 300 Points; Citigroup Posts Upbeat Earnings - Benzinga

01:09 AM
pulisher
12:20 PM

BioCryst Says Astria Therapeutics $700 Million Deal Gives 'Perfect Second Product Candidate' - Benzinga

12:20 PM
pulisher
11:50 AM

BioCryst Pharmaceuticals, Inc. agreed to acquire Astria Therapeutics, Inc.. - MarketScreener

11:50 AM
pulisher
11:25 AM

Shareholder Alert: The Ademi Firm investigates whether Astria Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders - PR Newswire

11:25 AM
pulisher
11:21 AM

Here’s Why Astria Therapeutics Stock (ATXS) Exploded Today - TipRanks

11:21 AM
pulisher
11:17 AM

BioCryst to Acquire Astria Therapeutics in $700 Million Deal - Contract Pharma

11:17 AM
pulisher
10:52 AM

BioCryst deepens rare diseases focus with $700 million deal for Astria - Reuters

10:52 AM
pulisher
10:15 AM

Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On TuesdayAmerican Resources (NASDAQ:AREC), Albertsons Companies (NYSE:ACI) - Benzinga

10:15 AM
pulisher
10:03 AM

ATXS Stocks Flying High: Too Late to Buy? - StocksToTrade

10:03 AM
pulisher
09:53 AM

BioCryst To Acquire Astria Therapeutics - citybiz

09:53 AM
pulisher
08:29 AM

ATXS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Astria Therapeutics, Inc. Is Fair to Shareholders - Business Wire

08:29 AM
pulisher
08:07 AM

BioCryst to Acquire Astria Therapeutics for $700 Million Includi - GuruFocus

08:07 AM
pulisher
08:06 AM

BioCryst Announces Acquisition of Astria Therapeutics (ATXS) at $13.00 Per Share - GuruFocus

08:06 AM
pulisher
08:04 AM

BioCryst (BCRX) to Acquire Astria Therapeutics in $700M Deal - GuruFocus

08:04 AM
pulisher
08:02 AM

BioCryst To Acquire Astria Therapeutics In $700M Deal - Stocktwits

08:02 AM
pulisher
08:00 AM

BioCryst Pharmaceuticals To Acquire Astria Therapeutics In $700 Million Cash-and-Stock Deal - Nasdaq

08:00 AM
pulisher
07:58 AM

BioCryst to acquire Astria Therapeutics for $700 million - Investing.com

07:58 AM
pulisher
07:48 AM

Astria Therapeutics (ATXS) Acquired by BioCryst in $700M Deal - GuruFocus

07:48 AM
pulisher
07:48 AM

BioCryst to buy Astria Therapeutics in $700 million deal - Yahoo Finance

07:48 AM
pulisher
07:37 AM

BioCryst To Acquire Astria Therapeutics In $700 Mln Cash-and-Stock Deal - Nasdaq

07:37 AM
pulisher
07:33 AM

Astria Therapeutics stock soars after BioCryst acquisition announcement, BioCryst falls By Investing.com - Investing.com Canada

07:33 AM
pulisher
07:32 AM

BioCryst Announces Merger with Astria Therapeutics - TipRanks

07:32 AM
pulisher
07:31 AM

BioCryst to buy Astria Therapeutics for $13 per share - MSN

07:31 AM
pulisher
07:20 AM

Combining price and volume data for Astria Therapeutics Inc.July 2025 Final Week & Risk Managed Investment Signals - newser.com

07:20 AM
pulisher
07:17 AM

BioCryst to acquire Astria Therapeutics, strengthening presence in HAE, transforming growth profile - MarketScreener

07:17 AM
pulisher
07:04 AM

BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile - GlobeNewswire

07:04 AM
pulisher
05:53 AM

What to do if you’re stuck in Astria Therapeutics Inc.July 2025 PostEarnings & Weekly Market Pulse Alerts - newser.com

05:53 AM
pulisher
05:34 AM

Can Astria Therapeutics Inc. stock maintain operating margins2025 Momentum Check & Fast Moving Stock Watchlists - newser.com

05:34 AM
pulisher
05:11 AM

How to forecast Astria Therapeutics Inc. trends using time seriesMarket Risk Report & Real-Time Buy Signal Alerts - newser.com

05:11 AM
pulisher
02:02 AM

Published on: 2025-10-14 01:02:46 - newser.com

02:02 AM
pulisher
Oct 13, 2025

BioCryst Pharmaceuticals To Acquire Astria In $700 Million Deal - Finimize

Oct 13, 2025
pulisher
Oct 13, 2025

Institutional scanner results for Astria Therapeutics Inc.2025 Technical Overview & Weekly High Return Forecasts - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Is it too late to sell Astria Therapeutics Inc.Swing Trade & Expert Verified Stock Movement Alerts - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

3 Biotech Stocks That Could More Than Triple if Their Trials Succeed - MSN

Oct 11, 2025
pulisher
Oct 11, 2025

3 Biotech Stocks That Could More Than Triple If Their Trials Succeed - Barchart.com

Oct 11, 2025
pulisher
Oct 10, 2025

Can Astria Therapeutics Inc. stock sustain institutional interest2025 Market Outlook & High Conviction Buy Zone Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Comparing Astria Therapeutics Inc. in custom built stock radars2025 Retail Activity & Verified Entry Point Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Visual analytics tools that track Astria Therapeutics Inc. performanceJuly 2025 Institutional & Scalable Portfolio Growth Methods - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Tick level data insight on Astria Therapeutics Inc. volatility2025 Winners & Losers & Technical Entry and Exit Tips - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Weiss Ratings Reaffirms Sell (D-) Rating for Astria Therapeutics (NASDAQ:ATXS) - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

H.C. Wainwright reiterates Buy rating on Astria Therapeutics stock at $20 - Investing.com Canada

Oct 09, 2025
pulisher
Oct 09, 2025

Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting - Business Wire

Oct 09, 2025
pulisher
Oct 09, 2025

Analyzing Astria Therapeutics Inc. with multi timeframe chartsEarnings Risk Summary & Reliable Price Breakout Signals - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How to interpret RSI for Astria Therapeutics Inc. stock2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Astria Therapeutics begins phase 3 long-term trial for HAE treatment - Investing.com Nigeria

Oct 08, 2025
pulisher
Oct 08, 2025

Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with - PharmiWeb.com

Oct 08, 2025
pulisher
Oct 08, 2025

Astria Therapeutics (ATXS) Begins Phase 3 Trial for Hereditary A - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Astria Therapeutics begins phase 3 long-term trial for HAE treatment By Investing.com - Investing.com South Africa

Oct 08, 2025
pulisher
Oct 08, 2025

Astria Therapeutics initiates the phase 3 ORBIT-EXPANSE long-term trial of navenibart in people with hereditary angioedema - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema - Business Wire

Oct 08, 2025
pulisher
Oct 08, 2025

Astria Therapeutics, Inc. $ATXS Stock Position Lifted by Farther Finance Advisors LLC - Defense World

Oct 08, 2025
pulisher
Oct 06, 2025

How strong is Astria Therapeutics Inc. stock balance sheetJuly 2025 Weekly Recap & Technical Pattern Based Buy Signals - newser.com

Oct 06, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):